FDA
approval
· 2025-11-03
FDA Approved: LINAGLIPTIN AND METFORMIN HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)
Summary
FDA approved the original application for a generic fixed-dose combination of linagliptin and metformin hydrochloride (Novadoz Pharmaceuticals LLC). The product…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for LINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE)